Added to YB: 2026-05-15
Pitch date: 2026-05-14
MEDP [bullish]
Medpace Holdings, Inc.
+1.14%
current return
Author Info
Aurelion Research is a research analyst with a passion for markets, specializing in high‑conviction ideas across shipping, offshore drilling, and thematic equity research. Sign up for the newsletter.
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
N/A
Pitch Price
$417.10
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.14
P/E
26.45
EV/Sales
N/A
Sector
Life Sciences Tools and Services
Category
growth
11. Medpace Holdings Inc (NASDAQ: MEDP)
MEDP (new position): Global CRO focused on small/mid-cap biotech. Differentiated via in-house ops, high organic growth, strong FCF, consistent margin expansion & buybacks. Positioned to capture AI drug discovery wave: 1) SMID client base aligns w/ AI biotech startups 2) Full-service model = turnkey solution for asset-light AI firms 3) Organic-only growth = unified data stack for faster AI tool deployment vs fragmented legacy CRO peers.
Read full article (2 min)